» Articles » PMID: 17639746

Osteoporosis Preventive Care in White and Black Women in Community Family Medicine Settings

Overview
Journal South Med J
Date 2007 Jul 21
PMID 17639746
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteoporosis has been studied predominantly in white postmenopausal women.

Materials And Methods: We performed a cross-sectional survey of a random sample of 400 women aged 45 years and older enrolled in a family medicine community-based research network. Participants responded to 42 items regarding osteoporosis screening and prevention during primary care visits. Odds ratios were calculated comparing black versus white women, adjusting for age, weight, fracture history, family history of osteoporosis, and practice site.

Results: Compared with black women, white women had 5.96 (95% CI 3.01, 11.79) times the adjusted odds of having a past bone density test, 2.97 (95% CI 1.57, 5.60) times the odds of discussing osteoporosis with their doctor, and 2.42 (95% CI 1.30, 4.50) times the odds of a physician recommendation to take calcium.

Conclusions: Disparities in osteoporosis preventive care were found between black and white women, after adjustment for other osteoporosis risk factors.

Citing Articles

Impact of COVID-19 pandemic on pharmacologic treatment of patients newly diagnosed with osteoporosis.

White M, Hisatomi L, Villegas A, Pina D, Garfinkel A, Agrawal G PLoS One. 2023; 18(9):e0291472.

PMID: 37703271 PMC: 10499214. DOI: 10.1371/journal.pone.0291472.


Osteoporosis Screening Disparities among Ethnic and Racial Minorities: A Systematic Review.

Calikyan A, Silverberg J, McLeod K J Osteoporos. 2023; 2023:1277319.

PMID: 37138642 PMC: 10151144. DOI: 10.1155/2023/1277319.


Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates.

Gu T, Eisenberg Lawrence D, Stephenson J, Yu J Clin Interv Aging. 2016; 11:1-8.

PMID: 26929609 PMC: 4760663. DOI: 10.2147/CIA.S97593.


Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement.

Golden S, Brown A, Cauley J, Chin M, Gary-Webb T, Kim C J Clin Endocrinol Metab. 2012; 97(9):E1579-639.

PMID: 22730516 PMC: 3431576. DOI: 10.1210/jc.2012-2043.


The effect modification of supplemental insurance on the relationship between race and bone mineral density screening in female Medicare beneficiaries.

Yoo J, Nakagawa S, Kim S J Immigr Minor Health. 2012; 14(6):912-7.

PMID: 22535021 DOI: 10.1007/s10903-012-9629-z.